Abstract
Background
Oral complications are commonly experienced by patients undergoing cancer therapies. The Oral Care Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) has completed nine systematic reviews including Bisphosphonate Osteonecrosis of the Jaw, Odontogenic/Periodontal Infection, Dysgeusia, Oral Fungal Infection, Osteoradionecrosis, Trismus, Oral Pain, Oral Viral Infection, and Xerostomia.
Methods
The aims of these reviews were to determine the prevalence of each oral complication, relationship with quality of life, economic impact, and formulation of guidelines based on the quality of the literature. The present article described the details of the methodology and statistical analysis utilized in these nine systematic reviews. Additionally, a summary of the quality of the literature from these oral complications is presented.
Conclusion
Oral complications associated with cancer therapies are common among cancer patients. The systematic reviews by the Oral Care Study Group of MASCC/ISOO provide a thorough assessment of the available literature for these oral complications.
Similar content being viewed by others
References
Dreizen S (1990) Description and incidence of oral complications. NCI Monogr 9:11–15
National Institutes of Health Consensus Development Conference on Oral Complications of Cancer Therapies: Diagnosis, Prevention, and Treatment. (1990) NCI Monogr 1-184
National Cancer Institute (2005) Cancer Literature in PubMed. Available from http://www.cancer.gov/search/cancer_literature/. Accessed 26 Sep
Smith BJ, Darzins PJ, Quinn M, Heller RF (1992) Modern methods of searching the medical literature. Med J Aust 157:603–611
Higgins JP, Green S (2005) Cochrane handbook for systematic reviews of interventions. [cited May 31]. Available from http://www.cochrane.dk/cochrane/handbook/hbook.htm
(1989) Oral complications of cancer therapies: diagnosis, prevention, and treatment. Available from http://consensus.nih.gov/1989/1989OralComplicationsCancerTherapy073html.htm. [cited Apr 17]; 7:1-11
Somerfield MR, Padberg JJ, Pfister DG, Bennett CL, Recht A, Smith TJ, Weeks JC, Winn RJ, Durant JR (2000) ASCO clinical practice guidelines: process, progress, pitfalls, and prospects. Class Pap Curr Comments 4:881–886
Baccaglini L, Brennan MT, Lockhart PB, Patton LL (2007) World Workshop on Oral Medicine IV: process and methodology for systematic review and developing management recommendations. Reference manual for management recommendations writing committees. OOOOE 103 Suppl:S3.e1-19
Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST, Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100:2026–2046
Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB, Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100:1995–2025
Berard A, Bravo G (1998) Combining studies using effect sizes and quality scores: application to bone loss in postmenopausal women. J Clin Epidemiol 51:801–807
Efron B (1993) An introduction to the bootstrap. Chapman & Hall, New York
Acknowledgments
We thank Bridget Loven, MLIS of the Information Resource Center at Carolinas Medical Center, Charlotte, NC, USA for completing the thorough literature searches.
Conflict of interest statement
None to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brennan, M.T., Elting, L.S. & Spijkervet, F.K.L. Systematic reviews of oral complications from cancer therapies, Oral Care Study Group, MASCC/ISOO: methodology and quality of the literature. Support Care Cancer 18, 979–984 (2010). https://doi.org/10.1007/s00520-010-0856-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-010-0856-3